Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- OSRH
- Price
- 0.46
- Stock movement down
- -0.04 (-7.34%)
- Company name
- OSR Holdings Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 11.80M
- Ent value
- 52.75M
- Price/Sales
- -
- Price/Book
- 0.09
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return (CAGR)
- -
- 3 year return (CAGR)
- -
- 5 year return (CAGR)
- -
- 10 year return (CAGR)
- -
Last updated: 2026-02-20
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
OSRH does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | 0.09 |
| EV to Sales | -582.82 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 25.67M |
| EPS (TTM) | -0.77 |
| FCF per share (TTM) | -0.30 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | -90.52K |
| Gross profit (TTM) | 463.20K |
| Operating income (TTM) | -14.09M |
| Net income (TTM) | -16.28M |
| EPS (TTM) | -0.77 |
| EPS (1y forward) | -1.09 |
Margins
Loading...
Margins data
| Gross margin (TTM) | -511.74% |
| Operating margin (TTM) | 15571.52% |
| Profit margin (TTM) | 17984.28% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 2.18M |
| Net receivables | 533.93K |
| Total current assets | 3.20M |
| Goodwill | 25.53M |
| Intangible assets | 148.15M |
| Property, plant and equipment | 463.52K |
| Total assets | 177.29M |
| Accounts payable | 7.66M |
| Short/Current long term debt | 50.37K |
| Total current liabilities | 15.03M |
| Total liabilities | 43.13M |
| Shareholder's equity | 134.16M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -3.76M |
| Capital expenditures (TTM) | 2.71M |
| Free cash flow (TTM) | -6.47M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -12.13% |
| Return on Assets | -9.18% |
| Return on Invested Capital | -11.75% |
| Cash Return on Invested Capital | -4.67% |
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.49 |
| Daily high | 0.50 |
| Daily low | 0.45 |
| Daily Volume | 608K |
| All-time high | 0.82 |
| 1y analyst estimate | 10.00 |
| Beta | 1.41 |
| EPS (TTM) | -0.77 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| OSRH | S&P500 | |
| Current price drop from All-time high | -43.71% | -1.82% |
| Highest price drop | -43.71% | -56.47% |
| Date of highest drop | 17 Feb 2026 | 9 Mar 2009 |
| Avg drop from high | -19.03% | -10.84% |
| Avg time to new high | 20 days | 12 days |
| Max time to new high | 56 days | 1805 days |
COMPANY DETAILS
Marketcap
11.80M
Marketcap category
Small-cap
Description
OSR Holdings, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Switzerland, and South Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma that is in phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatment of Wilms Tumor Protein (WT1); VXM08 for Carcinoembryonic antigen (CEA); and VXM10 for PD-L1. It is also developing design-augmented (DA) biologics comprising DRT-102, a clinical-stage asset for spinal fusion; and DRT-101, a pre-clinical stage asset for osteoarthritis. In addition, the company distributes neurovascular intervention medical device and systems. OSR Holdings, Inc. is based in Bellevue, Washington.
Employees
19
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner